Top accelerator startups

14,448 startups · 29 programs

Trestle Biotherapeutics

Active · Bioengineered kidneys for patients with kidney failure

7signal of 100 · rising 1
  • went through YCProgram · this site+4
  • team of 2Team size · YC's directory+2.5

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W21

All of W21

About Trestle Biotherapeutics

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

YC batch
W21 · Winter 2021
Status, per YC
Active
Category
Other
Team size
2
Location
San Diego, CA, USA
Checked
7h ago

YC tags: Biotech

Trestle Biotherapeutics in W21: 336 companies, 30% AI

Trestle Biotherapeutics: questions

Which YC batch was Trestle Biotherapeutics in?

Trestle Biotherapeutics was in Y Combinator's Winter 2021 batch (W21).

Is Trestle Biotherapeutics still active?

Y Combinator lists Trestle Biotherapeutics as active.

Where is Trestle Biotherapeutics based?

Trestle Biotherapeutics lists San Diego, CA, USA as its location on YC's directory.